首页> 外国专利> 1,3-Oxathiolan nucleoside analogues, pharmaceutical composition containing 1,3-oxathiolan nucleoside analogues and method of treatment of the viral infections

1,3-Oxathiolan nucleoside analogues, pharmaceutical composition containing 1,3-oxathiolan nucleoside analogues and method of treatment of the viral infections

机译:1,3-氧杂硫杂环戊烷核苷类似物,含有1,3-氧杂硫杂环戊烷核苷类似物的药物组合物和病毒感染的治疗方法

摘要

The invention relates to the 1,3-oxathiolan nucleoside analogues and use thereof in the treatment of viral infections. Summary of the invention consists in the fact that (-)-(cis)-4-amino-5-fluor-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidine-2-one represented by an absolutely stereochemical formula: CHFORM and pharmaceutically acceptable derivatives thereof possesses a far greater antiviral activity and a suddenly low toxicity in comparison with the corresponding (+)-enantiomer. The present compound and pharmaceutically acceptable derivatives thereof with an essentially free content of (+)-enantiomer can be used both in pure state and in compositions with pharmaceutically acceptable carriers and optionally with other therapeutical agents. Claims: 24
机译:本发明涉及1,3-氧杂硫杂环戊烷核苷类似物及其在治疗病毒感染中的用途。发明概述在于以下事实:(-)-(顺式)-4-氨基-5-氟-1-(2-羟甲基-1,3-氧杂硫杂环戊-5-基)-(1H)-嘧啶-2 -由绝对立体化学式表示的一个:及其药学上可接受的衍生物与相应的(+)-对映异构体相比具有更大的抗病毒活性和突然低的毒性。具有基本游离含量的(+)-对映异构体的本发明化合物及其药学上可接受的衍生物可以以纯净状态使用,也可以与药学上可接受的载体以及任选地与其他治疗剂一起用于组合物中。索赔:24

著录项

  • 公开/公告号MD1434B2

    专利类型

  • 公开/公告日2000-03-31

    原文格式PDF

  • 申请/专利权人 BIOCHEM PHARMA INC.;

    申请/专利号MD19950000114

  • 发明设计人 DIONNE GERVAIS;

    申请日1992-07-24

  • 分类号C07D411/04;C12P41/00;A61K3/505;

  • 国家 MD

  • 入库时间 2022-08-22 01:55:58

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号